GE HealthCare Technologies Inc

Jim Cramer says GE Healthcare’s unwarranted post-earnings plunge is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) April showers : The Dow Jones […]
Read More
Shares making the major moves premarket: Eli Lilly, 3M, McDonald’s and much more
Look at out the organizations generating headlines in advance of the bell. Eli Lilly — Shares popped approximately 7% right after the maker of the Mounjaro diabetes and body weight decline drug claimed initial-quarter altered earnings of $2.58 for every share, beating the consensus estimate of $2.46, in accordance to LSEG. Eli Lilly also hiked […]
Read More
Google companions with Bayer on new AI solution for radiologists
Google Cloud and the German health-treatment business Bayer on Tuesday introduced they are creating an artificial intelligence-driven system that aims to assistance radiologists diagnose individuals and operate by way of instances much more promptly. The platform’s generative AI flags anomalies in just images for radiologists to glimpse at, and it can also pull up pertinent […]
Read More
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for […]
Read More
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets bounce : Stocks kicked off […]
Read More
The news hitting a portfolio health-care name actually removes an overhang on the stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the artificial intelligence momentum trade. One day later, tech was […]
Read More
What Eli Lilly investors can learn from the slow launch of a competitor's drug
Club holding Eli Lilly is expecting to get approval for its Alzheimer’s treatment in the coming weeks, but investors looking for immediate financial success should temper their expectations. On its fourth-quarter earnings call Tuesday, rival drugmaker Biogen shared data that showed its therapy for the memory-robbing disease, Leqembi, is off to a slower-than-expected start. In […]
Read More
Jim Cramer praises GE following U.S. regulatory approval to develop nuclear fuel
CNBC’s Jim Cramer called out General Electric as a winner in the industrial sector for the strides it’s making in nuclear power. GE’s Verona Nuclear Fuel business said Wednesday it received approval from the U.S. Nuclear Regulatory Commission to manufacture, ship, and analyze the performance of higher enrichment fuel. These “regulatory milestones” will help the […]
Read More
Wall Street changes its tune on this healthcare stock. Why we were always bullish
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer price index Tuesday, retail sales Thursday, and the producer […]
Read More